2022 American Transplant Congress
Disparities in Liver Transplantation in Patients with HCC Diagnosis
*Purpose: Disparities in outcomes of hepatocellular carcinoma (HCC) have not been adequately studied, especially in the context of liver transplantation (LT). We sought to identify…2022 American Transplant Congress
Allocation Based on Acuity Circles Decreases Waiting Time for Liver Transplant Patients
Stanford University, Stanford, CA
*Purpose: In February, 2020, UNOS implemented a new liver allocation system incorporating a combination of acuity based on MELD/PELD score and distance from the donor…2022 American Transplant Congress
Late Liver Turn Downs: The Utilization and Impact of the Expedited Process
*Purpose: There is belief that the discard rates are higher for organs turned down late in the recovery process. The expedited liver (LI) pathway, allows…2022 American Transplant Congress
Galectin-3 is Predictive of 30-Day Acute Rejection Following Liver Transplantation
University of Colorado Anschutz Medical, Aurora, CO
*Purpose: Galectin-3 (Gal3) is a beta-galactoside binding lectin that plays a key role in inflammation and immune response. Studies on Gal3 in liver transplantation are…2022 American Transplant Congress
Characteristics and Outcomes of Anhepatic Patients Listed for Liver Retransplantation
1University of Michigan, Ann Arbor, MI, 2University of Pennsylvania, Philadelphia, PA
*Purpose: The frequency and outcomes of anhepatic patients listed for transplantation in the United States has not been previously described. The United Network for Organ…2022 American Transplant Congress
Changes in Health Equity Under Liver Acuity Circles Allocation
United Network for Organ Sharing, Richmond, VA
*Purpose: Acuity circles (AC) allocation was implemented on 2/4/2020 with a goal of removing DSA and region from liver allocation and sharing livers more broadly.…2022 American Transplant Congress
Differences in Post-Liver Transplant Hospitalizations by Patient Race
1Emory University, Atlanta, GA, 2Virginia Commonwealth University, Richmond, VA
*Purpose: Hospital admissions after liver transplant are common, costly, and associated with poor outcomes. While survival disparities are well-documented for Black liver recipients, little is…2022 American Transplant Congress
Benefits and Risks of Induction Immunosuppression Therapy in Pediatric Liver Transplantation
University of Pennsylvania, Philadelphia, PA
*Purpose: To investigate trends in induction therapy use in pediatric liver transplantation (LT) in the U.S. and evaluate the potential benefits and risks of induction…2022 American Transplant Congress
Plasma Galectin-3 is Predictive of Post-Transplant Infection in Pediatric Liver Transplant Recipients
University of Colorado Anschutz Medical, Aurora, CO
*Purpose: Galectin-3 (Gal3) is a beta-galactoside binding lectin that plays a key role in inflammation and immune response. Infectious complications are common among pediatric liver…2022 American Transplant Congress
Assessment of Insulin Utilization for Early Post-Transplant Glycemic Control in Liver Transplant
*Purpose: Transient hyperglycemia after liver transplant (LT) is common due to the use of high-dose steroids at the time of transplant, but some patients may…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 50
- Next Page »